ICICI Prudential Contra Fund

A Contra Fund scheme from ICICI Prudential Mutual Fund. Figures below are for the Direct · Growth plan (ISIN INF109K1A682).

NAV ₹10.5000 on 13 November 2026.

Expense ratio

Total expense ratio 0.96% a year for the Direct · Growth plan, as AMFI published it on 28 October 2026: base expense ratio 0.82%, brokerage 0.00%, transaction costs 0.00%, statutory levies including GST 0.14%.

Returns and risk

PeriodReturn a yearVolatilityWorst fallSharpeSortino

Too little NAV history for the 1, 3, 5, 10-year figures.

Not ranked in its category: it has too little NAV history.

Largest holdings

Top 10 (October 2026 disclosure). Company shares make up 84.5% of the portfolio.

  1. TREPS (other) — 14.90%
  2. HDFC Bank Limited — 9.36%
  3. Natco Pharma Limited — 6.59%
  4. Britannia Industries Limited — 4.88%
  5. Avenue Supermarts Limited — 4.67%
  6. Medplus Health Services Limited — 4.61%
  7. SHREE CEMENT LIMITED — 4.35%
  8. Bajaj Finserv Limited — 4.21%
  9. Tata Motors Passenger Vehicles Limited — 4.12%
  10. Pidilite Industries Limited — 3.84%

Plans

Other funds in Contra Fund

All 6 funds in Contra Fund · Compare this fund with another

Past returns are history, not a forecast. XIRRO describes funds and portfolios; it is information, not investment advice.